Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)

Revenue by Segment

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Dec 31, 2015
Pharmaceuticals	44.39B	39.27B	34.67B	29.49B	25.61B
Pharmaceuticals Growth	13.05%	13.26%	17.55%	15.16%	12.25%
Total	44.39B	39.27B	34.67B	29.49B	25.61B
Total Growth	13.05%	13.26%	17.55%	15.16%	12.25%

Revenue by Geography

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Dec 31, 2015
Bangladesh	41.28B	36.33B	31.89B	26.33B	22.81B
Bangladesh Growth	13.61%	13.94%	21.11%	15.44%	12.35%
Export	2.96B	2.76B	2.69B	3.12B	2.75B
Export Growth	7.06%	2.91%	-14.05%	13.53%	9.96%
Unallocated	152.62M	169.26M	95.04M	38.39M	51.16M
Unallocated Growth	-9.83%	78.09%	147.60%	-24.97%	291.87%
Total	44.39B	39.27B	34.67B	29.49B	25.61B
Total Growth	13.05%	13.26%	17.55%	15.16%	12.25%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 4, 2026

Data Sources Report a data error